Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

METROPOLIS HEALTHCARE vs DR. LAL PATHLABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    METROPOLIS HEALTHCARE DR. LAL PATHLABS METROPOLIS HEALTHCARE/
DR. LAL PATHLABS
 
P/E (TTM) x 53.0 76.4 69.4% View Chart
P/BV x 19.4 25.5 76.1% View Chart
Dividend Yield % 0.3 0.5 55.6%  

Financials

 METROPOLIS HEALTHCARE   DR. LAL PATHLABS
EQUITY SHARE DATA
    METROPOLIS HEALTHCARE
Mar-21
DR. LAL PATHLABS
Mar-21
METROPOLIS HEALTHCARE/
DR. LAL PATHLABS
5-Yr Chart
Click to enlarge
High Rs2,3452,735 85.7%   
Low Rs1,1501,305 88.1%   
Sales per share (Unadj.) Rs195.3189.7 102.9%  
Earnings per share (Unadj.) Rs35.935.6 100.8%  
Cash flow per share (Unadj.) Rs44.944.8 100.1%  
Dividends per share (Unadj.) Rs8.0020.00 40.0%  
Avg Dividend yield %0.51.0 46.2%  
Book value per share (Unadj.) Rs136.6144.6 94.4%  
Shares outstanding (eoy) m51.1183.34 61.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x8.910.6 84.0%   
Avg P/E ratio x48.756.8 85.8%  
P/CF ratio (eoy) x38.945.1 86.4%  
Price / Book Value ratio x12.814.0 91.6%  
Dividend payout %22.356.2 39.7%   
Avg Mkt Cap Rs m89,308168,365 53.0%   
No. of employees `000NANA-   
Total wages/salary Rs m1,9862,737 72.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m9,98015,813 63.1%  
Other income Rs m120513 23.5%   
Total revenues Rs m10,10016,326 61.9%   
Gross profit Rs m2,8984,363 66.4%  
Depreciation Rs m459772 59.5%   
Interest Rs m116160 72.2%   
Profit before tax Rs m2,4433,944 61.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m610979 62.3%   
Profit after tax Rs m1,8332,965 61.8%  
Gross profit margin %29.027.6 105.2%  
Effective tax rate %25.024.8 100.5%   
Net profit margin %18.418.7 98.0%  
BALANCE SHEET DATA
Current assets Rs m6,44711,452 56.3%   
Current liabilities Rs m2,4022,743 87.6%   
Net working cap to sales %40.555.1 73.6%  
Current ratio x2.74.2 64.3%  
Inventory Days Days2921 139.5%  
Debtors Days Days45015 2,921.3%  
Net fixed assets Rs m4,1454,881 84.9%   
Share capital Rs m102833 12.3%   
"Free" reserves Rs m6,87911,219 61.3%   
Net worth Rs m6,98112,053 57.9%   
Long term debt Rs m01 0.0%   
Total assets Rs m10,59216,333 64.8%  
Interest coverage x22.125.6 86.3%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.91.0 97.3%   
Return on assets %18.419.1 96.2%  
Return on equity %26.324.6 106.8%  
Return on capital %36.734.0 107.7%  
Exports to sales %00-   
Imports to sales %00.7 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA105 0.0%   
Fx inflow Rs m130143 90.9%   
Fx outflow Rs m10105 9.4%   
Net fx Rs m12038 317.4%   
CASH FLOW
From Operations Rs m2,4903,982 62.5%  
From Investments Rs m617-2,120 -29.1%  
From Financial Activity Rs m-327-1,386 23.6%  
Net Cashflow Rs m2,794476 587.3%  

Share Holding

Indian Promoters % 50.4 55.2 91.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 43.2 32.6 132.7%  
FIIs % 28.6 26.8 106.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 49.6 44.8 110.9%  
Shareholders   33,527 125,953 26.6%  
Pledged promoter(s) holding % 3.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare METROPOLIS HEALTHCARE With:   NARAYANA HRUDAYALAYA  MEDINOVA DIAG.  CONSTRONICS INFRA  SHALBY   LOTUS EYE CARE  



Today's Market

Sensex Ends Above 61,000-Mark, Nifty Tops 18,300; Adani Ports, Wipro & Grasim Rally 5%(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended on a strong note.

Related Views on News

DR. LAL PATHLABS 2020-21 Annual Report Analysis (Annual Result Update)

Aug 12, 2021 | Updated on Aug 12, 2021

Here's an analysis of the annual report of DR. LAL PATHLABS for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of DR. LAL PATHLABS. Also includes updates on the valuation of DR. LAL PATHLABS.

DR. LAL PATHLABS Announces Quarterly Results (1QFY22); Net Profit Up 370.8% (Quarterly Result Update)

Aug 3, 2021 | Updated on Aug 3, 2021

For the quarter ended June 2021, DR. LAL PATHLABS has posted a net profit of Rs 1 bn (up 370.8% YoY). Sales on the other hand came in at Rs 6 bn (up 128.0% YoY). Read on for a complete analysis of DR. LAL PATHLABS's quarterly results.

More Views on News

Most Popular

Is it Time to Switch from Tata Power to NTPC?(Profit Hunter)

Oct 11, 2021

Given the huge run up in Tata Power, does it make sense to switch to NTPC?

This Proxy EV Stock Just got a Power Crisis Boost(Profit Hunter)

Oct 8, 2021

After months of research, I've come across few stocks that excite me far more than the mainstream electric vehicle companies.

Rs 1 Lakh Invested in These Cryptos at the Start of 2021 Became Rs...(Views On News)

Oct 8, 2021

These cryptos would have multiplied investors' wealth by as much as 10,000% in just nine months.

Top 5 'Digital India' Stocks(Views On News)

Oct 6, 2021

These companies are leading the Government's US$1 tn 'Digital India' initiative.

5 Exciting 'Unlisted' Companies and How to Play Them(Views On News)

Oct 7, 2021

Here's how you can invest in some of the most exciting start-ups of the decade.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

METROPOLIS HEALTHCARE SHARE PRICE


Oct 14, 2021 (Close)

TRACK METROPOLIS HEALTHCARE

  • Track your investment in METROPOLIS HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON METROPOLIS HEALTHCARE

METROPOLIS HEALTHCARE - CONSTRONICS INFRA COMPARISON

COMPARE METROPOLIS HEALTHCARE WITH

MARKET STATS